Published in BMC Geriatr on July 01, 2009
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
Modeling valuations for EuroQol health states. Med Care (1997) 21.66
The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care (2001) 15.36
The estimation of a preference-based measure of health from the SF-36. J Health Econ (2002) 14.18
Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care (2000) 8.63
Association of depression and diabetes complications: a meta-analysis. Psychosom Med (2001) 8.30
Multiple imputation in health-care databases: an overview and some applications. Stat Med (1991) 7.89
Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med (2000) 7.79
Costs, effects and C/E-ratios alongside a clinical trial. Health Econ (1995) 6.63
Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ (2001) 6.48
Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care (2004) 6.09
Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care (2002) 5.60
The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med (2006) 5.51
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health (2005) 5.25
Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care (2003) 4.92
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. Health Econ (2004) 4.92
Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ (1997) 4.43
Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ (2005) 4.40
What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses. BMJ (1996) 3.92
Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol (1998) 3.57
Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. JAMA (1997) 3.36
The CE plane: a graphic representation of cost-effectiveness. Med Decis Making (1990) 2.93
Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol (2005) 2.84
Validating the EQ-5D with time trade off for the German population. Eur J Health Econ (2005) 2.65
Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry (2005) 2.62
Diabetes, depression, and quality of life: a population study. Diabetes Care (2004) 2.60
Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care (2006) 2.36
A multiple imputation strategy for clinical trials with truncation of patient data. Stat Med (1995) 2.20
Cost-of-illness studies of depression: a systematic review. J Affect Disord (2006) 1.81
Cardiac risk factors in patients with diabetes mellitus and major depression. J Gen Intern Med (2004) 1.67
Potentially modifiable factors associated with disability among people with diabetes. Psychosom Med (2005) 1.56
Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess (1999) 1.39
Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method. Med Decis Making (1998) 1.39
Self-reports of health-care utilization: diary or questionnaire? Int J Technol Assess Health Care (2005) 1.35
The analysis of incomplete cost data due to dropout. Health Econ (2005) 1.35
Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care (2003) 1.27
Cost measurement in economic evaluations of health care: whom to ask? Med Care (2004) 1.22
Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med (2005) 1.21
Methods to analyse cost data of patients who withdraw in a clinical trial setting. Pharmacoeconomics (2003) 1.14
Impact of antidepressant drug adherence on comorbid medication use and resource utilization. Arch Intern Med (2005) 1.12
Patient and informal caregiver time in cost-effectiveness analysis. A response to the recommendations of the Washington Panel. Int J Technol Assess Health Care (1998) 0.85
Economic evidence in affective disorders: a review. Eur J Health Econ (2004) 0.82
The missing link: on the line between C and E. Health Econ (2003) 0.76
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71
Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol (2012) 2.39
A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. J Clin Psychopharmacol (2005) 2.19
Changes in dialysis treatment modalities during institution of flat rate reimbursement and quality assurance programs. Kidney Int (2013) 2.14
Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord (2004) 2.04
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 1.98
Discrepancies in national incidence trends for hip fracture: why does Austria have such a high incidence? Wien Klin Wochenschr (2010) 1.98
Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment. Neurobiol Aging (2005) 1.88
Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care (2012) 1.78
Influence of general self-efficacy on the effects of a school-based universal primary prevention program of depressive symptoms in adolescents: a randomized and controlled follow-up study. J Child Psychol Psychiatry (2005) 1.69
Coping with amyotrophic lateral sclerosis: an integrative view. J Neurol Neurosurg Psychiatry (2010) 1.54
Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis (2005) 1.51
Sudden and unexpected deaths after the administration of hexavalent vaccines (diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, Haemophilius influenzae type b): is there a signal? Eur J Pediatr (2004) 1.48
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. J Clin Psychiatry (2003) 1.41
Management of diabetes mellitus in infants. Nat Rev Endocrinol (2011) 1.40
[Evidence-based treatment of depression: what does the new S3- and national healthcare guideline Unipolar Depression really recommend?]. Z Psychosom Med Psychother (2010) 1.40
Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair (2005) 1.40
CNS manifestations of Fabry's disease. Lancet Neurol (2006) 1.29
Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000. Arch Intern Med (2005) 1.28
Hip fractures in institutionalized elderly people: incidence rates and excess mortality. J Bone Miner Res (2008) 1.25
To take or not to take: decision-making about antiretroviral treatment in people living with HIV/AIDS. AIDS Patient Care STDS (2006) 1.24
Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol (2010) 1.21
Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990-2005: results of the Leverkusen Amputation Reduction Study (LARS). Diabetes Care (2007) 1.20
Functional relevant loss of long association fibre tracts integrity in early Alzheimer's disease. Neuropsychologia (2007) 1.18
FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment. Psychiatry Res (2007) 1.18
Deriving age-specific incidence from prevalence with an ordinary differential equation. Stat Med (2012) 1.17
Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm. Psychother Psychosom (2010) 1.14
School-based prevention of depressive symptoms in adolescents: a 6-month follow-up. J Am Acad Child Adolesc Psychiatry (2004) 1.13
Quantification of brain tissue alterations in Fabry disease using diffusion-tensor imaging. Acta Paediatr Suppl (2007) 1.12
Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. J Affect Disord (2010) 1.12
APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res (2007) 1.09
Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol (2009) 1.08
Categories of glucose tolerance and continuous glycemic measures and mortality. Eur J Epidemiol (2011) 1.08
Assessing health-related quality of life in patients with restless legs syndrome. Sleep Med (2008) 1.07
"It's my body'': does patient involvement in decision making reduce decisional conflict? Med Decis Making (2007) 1.07
Effects of coping-oriented couples therapy on depression: a randomized clinical trial. J Consult Clin Psychol (2008) 1.06
Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study. Eur J Epidemiol (2007) 1.06
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ (2012) 1.05
Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study. Ann Med (2010) 1.04
Validity of the ALS-Depression-Inventory (ADI-12)--a new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. J Affect Disord (2008) 1.03
Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus. Psychiatry Res (2006) 1.03
Hip fracture incidence in the elderly in Austria: an epidemiological study covering the years 1994 to 2006. BMC Geriatr (2008) 1.02
Cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA Survey 2000. Diabetes Care (2004) 1.01
Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. Diabetes Care (2006) 1.01
JuSt - a multimodal program for treatment of insomnia in adolescents: a pilot study. Nat Sci Sleep (2010) 1.00
Depression and anxiety: their predictive function for weight loss in obese individuals. Obes Facts (2009) 1.00
Can delusions be self-assessed? Concordance between self- and observer-rated delusions in schizophrenia. Psychiatry Res (2010) 0.99
Impulsivity in binge eating disorder: food cues elicit increased reward responses and disinhibition. PLoS One (2013) 0.99
Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany. Eur J Epidemiol (2012) 0.99
Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment. Biol Psychiatry (2004) 0.99
A randomized controlled trial of a cognitive-behavioral program for the prevention of depression in adolescents compared with nonspecific and no-intervention control conditions. J Couns Psychol (2013) 0.98
Is inflammation a causal chain between low socioeconomic status and type 2 diabetes? Results from the KORA Survey 2000. Eur J Epidemiol (2006) 0.98
Physical activity, leisure habits and obesity in first-grade children. Eur J Cardiovasc Prev Rehabil (2004) 0.98
Late structural alterations of cerebral white matter in long-term survivors of childhood leukemia. J Magn Reson Imaging (2008) 0.98
Attentional processing of food pictures in individuals with anorexia nervosa--an eye-tracking study. Biol Psychiatry (2010) 0.97
Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004. Diabetes Care (2007) 0.97
Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care (2009) 0.97
Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation: survival in a population-based 5-year cohort in Germany. Diabetes Care (2011) 0.95
Intuitive eating is associated with interoceptive sensitivity. Effects on body mass index. Appetite (2013) 0.95
The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol Dial Transplant (2010) 0.95
Increased use of hip protectors in nursing homes: economic analysis of a cluster randomized, controlled trial. J Am Geriatr Soc (2005) 0.94
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. Neuropsychopharmacology (2002) 0.94
Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge. Neuroimage (2006) 0.93
Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci (2003) 0.91
The EVIDENT-trial: protocol and rationale of a multicenter randomized controlled trial testing the effectiveness of an online-based psychological intervention. BMC Psychiatry (2013) 0.91
Response in individuals with and without foreign background and application to the National Cohort in Germany: which factors have an effect? Int J Public Health (2014) 0.91
Psychosocial factors in subjects with thyroid-associated ophthalmopathy. Thyroid (2002) 0.91
[Psychosocial burden and subjective experience of melanoma patients in the ambulant follow-up]. Psychother Psychosom Med Psychol (2003) 0.90
Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings. J Alzheimers Dis (2011) 0.90
Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects. World J Biol Psychiatry (2008) 0.89
Is impaired set-shifting a feature of "pure" anorexia nervosa? Investigating the role of depression in set-shifting ability in anorexia nervosa and unipolar depression. Psychiatry Res (2012) 0.89
Acute stress impairs recognition for positive words--association with stress-induced cortisol secretion. Stress (2004) 0.89
Frontal alpha-asymmetry in adults with attention deficit hyperactivity disorder: replication and specification. Biol Psychol (2011) 0.89
Behavioral medicine interventions in diabetes. Curr Opin Psychiatry (2010) 0.88
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. Am J Med Genet B Neuropsychiatr Genet (2007) 0.88
Costs of dialysis--a regional population-based analysis. Nephrol Dial Transplant (2009) 0.88
Remarkable decline in hip fracture incidence in younger age groups in Germany. Am J Public Health (2007) 0.88
Irritable bowel syndrome symptoms among German students: prevalence, characteristics, and associations to somatic complaints, sleep, quality of life, and childhood abdominal pain. Eur J Gastroenterol Hepatol (2011) 0.88
First effects of a multicomponent treatment for sleep disorders in children. Nat Sci Sleep (2010) 0.88
Depression, posttraumatic stress, and risk factors following spinal cord injury. Int J Behav Med (2014) 0.87
Therapeutic monitoring of new antipsychotic drugs. Ther Drug Monit (2004) 0.87
Impact of diabetes on costs before and after major lower extremity amputations in Germany. J Diabetes Complications (2013) 0.87
Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study. J Neurol (2006) 0.86
Direction of associations between added sugar intake in early childhood and body mass index at age 7 years may depend on intake levels. J Nutr (2011) 0.86
Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression. Eur Arch Psychiatry Clin Neurosci (2011) 0.86
Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. World J Biol Psychiatry (2007) 0.86
Blood glucose testing and primary prevention of diabetes mellitus type 2--evaluation of the effect of evidence based patient information. BMC Public Health (2010) 0.85
Health-related quality of life among German youths with early-onset and long-duration type 1 diabetes. Diabetes Care (2012) 0.85
Antihypertensive treatment and risk of dementia: a retrospective database study. Int J Clin Pharmacol Ther (2012) 0.85
Inverted-U function between salivary cortisol and retrieval of verbal memory after hydrocortisone treatment. Behav Neurosci (2005) 0.85
Mindfulness-based cognitive therapy (MBCT), cognitive style, and the temporal dynamics of frontal EEG alpha asymmetry in recurrently depressed patients. Biol Psychol (2011) 0.85